LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare and Non-Rare Monogenic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2MAP5Pc
via IFTTT